Damage control hematology: the impact of a trauma exsanguination protocol on survival

This is a discussion on Damage control hematology: the impact of a trauma exsanguination protocol on survival within the Medical Articles and Abstracts forum; Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product ...


Notices

 
LinkBack Thread Tools Search this Thread Rate Thread Display Modes

Reply
  #1 (permalink)  
Old 08-07-2008, 09:31 PM
Sharon Grant's Avatar
Moderator
 
Join Date: Dec 2003
Posts: 442
Thanks: 73
Thanked 163 Times in 82 Posts
Sharon Grant is on a distinguished road
Damage control hematology: the impact of a trauma exsanguination protocol on survival

Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization.


Cotton BA, Gunter OL, Isbell J, Au BK, Robertson AM, Morris JA Jr, St Jacques P, Young PP.

Departments of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA. bryan.cotton@vanderbilt.edu


BACKGROUND: The importance of early and aggressive management of trauma- related coagulopathy remains poorly understood. We hypothesized that a trauma exsanguination protocol (TEP) that systematically provides specified numbers and types of blood components immediately upon initiation of resuscitation would improve survival and reduce overall blood product consumption among the most severely injured patients. METHODS: We recently implemented a TEP, which involves the immediate and continued release of blood products from the blood bank in a predefined ratio of 10 units of packed red blood cells (PRBC) to 4 units of fresh frozen plasma to 2 units of platelets. All TEP activations from February 1, 2006 to July 31, 2007 were retrospectively evaluated. A comparison cohort (pre-TEP) was selected from all trauma admissions between August 1, 2004 and January 31, 2006 that (1) underwent immediate surgery by the trauma team and (2) received greater than 10 units of PRBC in the first 24 hours. Multivariable analysis was performed to compare mortality and overall blood product consumption between the two groups. RESULTS: Two hundred eleven patients met inclusion criteria (117 pre-TEP, 94 TEP). Age, sex, and Injury Severity Score were similar between the groups, whereas physiologic severity (by weighted Revised Trauma Score) and predicted survival (by trauma-related Injury Severity Score, TRISS) were worse in the TEP group (p values of 0.037 and 0.028, respectively). After controlling for age, sex, mechanism of injury, TRISS and 24-hour blood product usage, there was a 74% reduction in the odds of mortality among patients in the TEP group (p = 0.001). Overall blood product consumption adjusted for age, sex, mechanism of injury, and TRISS was also significantly reduced in the TEP group (p = 0.015). CONCLUSIONS: We have demonstrated that an exsanguination protocol, delivered in an aggressive and predefined manner, significantly reduces the odds of mortality as well as overall blood product consumption.

Damage control hematology: the impact of a trauma ...[J Trauma. 2008] - PubMed Result
__________________
Sharon Grant
Editorial Team
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
The Following User Says Thank You to Sharon Grant For This Useful Post:
Bob Jordan (08-07-2008)
Reply
Tags
control, damage, exsanguination, hematology, impact, protocol, survival, trauma



Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 
Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes Rate This Thread
Rate This Thread:

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On
Trackbacks are On
Pingbacks are On
Refbacks are On

Similar Threads
Thread Thread Starter Forum Replies Last Post
Results of Blood Substitute Trial Show No Survival Advantage to Trauma Patients Tony Paskitti News and Hot Topics such as Hepatitis C, SARS and AIDS 5 11-14-2007 08:51 AM
Recombinant activated factor VII as an adjunctive therapy for bleeding control trauma Jan B. Wade Medical Articles and Abstracts 0 02-05-2007 10:20 PM
Postpartum Protocol Mark Jacobson New Members 5 05-10-2005 05:43 PM
GI Bleed Protocol bhubbs Ask a Professional 1 08-26-2004 11:56 AM
Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood prod Jan B. Wade Medical Articles and Abstracts 0 02-06-2004 12:04 PM